
Researchers Call for More Data on Impact of Social Determinants of Health for Treatment of Menopause
Social determinants of health have significant impacts on health and quality of life, but little is known about the impact during menopause.

Social determinants of health have significant impacts on health and quality of life, but little is known about the impact during menopause.

Esaxerenone is a nonsteroidal mineralocorticoid receptor blocker that is being studied for its effectiveness for diabetes-associated mineralocorticoid receptor-related hypertension.

In the aftermath of natural disasters, pharmacists play an essential role in the disaster relief team.

Invasive pneumococcal disease is a cause of morbidity and mortality in the US, despite the availability of vaccination against the disease.

The new approval is in line with recommendations that suggest booster vaccination for older adults and patients aged 12 to 64 with at least 1 or more underlying risk factors.

Although there is no cure for MS, treatment focuses on recovery from attacks, reducing relapse, slowing disease progression, and managing multiple sclerosis symptoms.

The results place emphasis on female parents with low socioeconomic status for both declines in mental and physical health.

The results show promise, as vision typically improves the most during the first 4 weeks, but with lamivudine, vision continued to improve in the following 4 weeks.

The new approval is for a first-in-class TRPM8 receptor agonist to stimulate corneal sensory nerves to increase natural tear production.

The replacement therapy is indicated for patients 5 years and older, marking the first approval for an oral solution form of hydrocortisone.

The use of the terminology can alter the meaning when assigned to patients’ behaviors, unintentionally implying that barriers such as poverty or systemic racism are due to poor behavior or efforts.

The data show a decrease in all-cause mortality for sustained midlife weight loss achieved without surgical or pharmacological interventions.

This designation follows Hadlima’s low-concentration prefilled syringes and single-dose vials, which were designated in June 2024.

Pharmacists play a critical role in vaccination and education for patients about the evolving infectious disease landscape.

Ustekinumab is a medication used to treat and manage inflammatory conditions, including psoriasis, psoriatic arthritis, and inflammatory bowel disease.

By protecting pregnant patients from cardiometabolic risk factors, healthier blood pressure can be promoted for children.

Triptans are often a first-line treatment for migraine and can be used to treat menstrual migraine and cluster headaches.

Acetaminophen exposure can increase the risk of perforation, ulceration, bleeding, heart failure, hypertension, and chronic kidney disease.

Adalimumab-aaty (Yuflyma) prefilled syringes and autoinjectors are now fully interchangeable with the reference product adalimumab (Humira) across marketed dosage forms and strengths.

The supplemental new drug application for roflumilast (Zoryve) is approved for adult and pediatric patients 12 years and older.

The new program aims to reduce costs for patients, with savings estimated at as much as $3600 per year.

Importing prescription drugs from Canada has been met with criticism, such as weakening the pharmaceutical supply chain and posing increased risks to patient safety.

Patients included in the study were aged 6 to 17 years with attention deficit/hyperactivity disorder (ADHD).

Pharmacists can substitute ustekinumab with the biosimilar at the pharmacy level, depending on their state laws.

V116 is noninferior to 23-valent pneumococcal polysaccharide vaccine (PPSV23) for all 12 common serotypes and superior to 9 unique serotypes.

Approximately 67% of adults in the US know that vaccines do not cause autism in children, declining significantly from 74% in 2021.

However, there is no association between cortisol and tau pathology.

Glucagon-like peptide-1 receptor agonists have been associated with improvements in quality of life (QOL), restrained eating, and emotional eating behavior.

Novavax’s COVID-19 vaccine has been available in the US under emergency use authorization since July 2022.

Investigators note that the long-term effects of attention deficit/hyperactivity disorder (ADHD) medication for children remain lacking.